Ruxolitinib-induced reactivation of cytomegalovirus and Epstein-Barr virus in graft-versus-host disease.
Leuk Res
; 125: 107005, 2023 02.
Article
in En
| MEDLINE
| ID: mdl-36580876
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cytomegalovirus Infections
/
Hematopoietic Stem Cell Transplantation
/
Epstein-Barr Virus Infections
/
Graft vs Host Disease
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Leuk Res
Year:
2023
Document type:
Article
Country of publication: